according to newsmax
Shingles Vaccine Remains Effective for Four Years
Shingles Vaccine Remains Effective for Four Years
GlaxoSmithKline Plc's experimental shingles vaccine remained effective for at least four years in a study, unlike Merck & Co.'s competing Zostavax, which loses efficacy over time.People who received the two-dose Shingrix vaccine had an 88 percent lower risk of developing shingles in the fourth year after vaccination, compared with a 91 percent reduction over the entire period of the late-stage trial, according to results published Wednesday in the New England Journal of Medicine.Shingles is caused by the varicella zoster virus -- the same member of the herpes family that causes chickenpox.
moreover from techtimes
New Shingles Vaccine Proving To Be Effective In Testing
New Shingles Vaccine Proving To Be Effective In Testing
AdvertisementAn experimental vaccine by GlaxoSmithKline against shingles is proving to be effective in testing, as it offers lasting protection for most of the older adults who receive it.Shingles is characterized by itchy and painful rashes that develop on one side of the body, caused by the reactivation of the dormant chicken pox virus.The risk of acquiring shingles increases as people grow older.
in the same way immortal
New, More Effective Vaccine For Shingles Appears Promising
New, More Effective Vaccine For Shingles Appears Promising
An experimental vaccine to treat shingles may be a viable solution for most older adults, according to a new clinical trial.Shingles is caused by a reactivation of the dormant virus behind chickenpox.It is a painful rash on one side of the body or the face that usually clears up in a few weeks.
No comments:
Post a Comment